BROADCASTS.com

Every week, The American Journal of Managed Care\xae\xa0recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.\n\nThis week, the top managed care news included uncertainty surrounding the fate of the Affordable Care Act's individual mandate; a study finding Medicare beneficiaries may be paying more for some generics than brand-name drugs; the Trump administration proposing 5 new payment models to transform kidney disease care.\n\nRead more about the stories in this podcast:\nAppeals Court Shows Uncertainty Over Constitutionality of ACA's Individual Mandate: https://www.ajmc.com/focus-of-the-week/appeals-court-shows-uncertainty-over-constitutionality-of-acas-individual-mandate\nMedicare Beneficiaries May Pay More for Some Generics Than Brand-Name Drugs: https://www.ajmc.com/focus-of-the-week/medicare-beneficiaries-may-pay-more-for-some-generics-than-brandname-drugs\nDespite Growth, Uptake of Downside Risk in ACO Contracts Remains Low: https://www.ajmc.com/focus-of-the-week/despite-growth-uptake-of-downside-risk-in-aco-contracts-remains-low\nHHS Unveils 5 New Payment Models to Transform Kidney Disease Care: https://www.ajmc.com/newsroom/hhs-unveils-5-new-payment-models-to-transform-kidney-disease-care\nEvidence-Based Diabetes Management\u2014June 2019: https://www.ajmc.com/journals/evidence-based-diabetes-management/2019/june-2019